Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade <i>IDH</i>-mutant gliomasYu Yao, Nancy Ann Oberheim Bush, Bruce H. Wainer et al.|Neuro-Oncology|2021Cited by 127
PATH-12. TEMOZOLOMIDE-INDUCED HYPERMUTATION IS ASSOCIATED WITH HIGH-GRADE TRANSFORMATION, DISTANT RECURRENCE AND REDUCED SURVIVAL IN INITIALLY LOW GRADE IDH-MUTANT GLIOMASYu Yao, Nancy Ann Oberheim Bush, Javier Villanueva‐Meyer et al.|Neuro-Oncology|2020Cited by 2
CTNI-46. PIVOTAL STUDY TO EVALUATE SAFETY AND EFFICACY OF EXABLATE MODEL 4000 USING MICROBUBBLE RESONATORS TO TEMPORARILY MEDIATE BLOOD-BRAIN BARRIER DISRUPTION FOR LIQUID BIOPSY IN GLIOBLASTOMA (LIBERATE)Manmeet S. Ahluwalia, Graeme F. Woodworth, John de Groot et al.|Neuro-Oncology|2022Cited by 1
PATH-29. CLINICAL SIGNIFICANCE OF TEMOZOLOMIDE-INDUCED SOMATIC HYPERMUTATION IN INITIALLY LOW-GRADE IDH-MUTANT DIFFUSE GLIOMASYu Yao, Nancy Ann Oberheim Bush, Stephanie Hilz et al.|Neuro-Oncology|2018Cited by 0
EPCO-01. EPIGENETIC REPROGRAMMING SHAPES THE MOLECULAR AND CELLULAR LANDSCAPE OF SCHWANNOMASiyuan Liu, David R. Raleigh, Tim Casey-Clyde et al.|Neuro-Oncology|2022Cited by 0